Financial Management Investment Analysis
Financial Management Investment Analysis
I would recommend that Brilliant Bhd. proceed with the investment in the new-age electronic component technology. The key justifications include the potential strategic advantages of penetrating innovative market segments, enhancing competitive position due to superior product performance, and aligning with sustainability trends. Financially, the calculated NPV of the project, when adjusted for capital allowance benefits and operational cash flows, should meet or exceed the company's WACC, indicating positive financial returns. Additionally, this investment aligns with the company's goal to revitalize growth and adjust to market demands, thereby mitigating the risk of decline in coming years .
Demand forecasting is critical in evaluating Duo Co's investment as it determines the utilization and revenue generation capacity of the new machine. Accurate forecasts ensure the additional capacity is economically justified. In financial analysis, forecasts should be stress-tested under different scenarios (e.g., demand fluctuations, economic downturns) to evaluate their impact on cash flows and NPV. Addressing them involves incorporating a sensitivity analysis to assess the robustness of the investment under various demand conditions, ensuring that even under pessimistic forecasts, the project remains financially viable and meets the company's return requirements .
Acquiring the licence for the new-age electronic component could provide Brilliant Bhd. several strategic advantages. Firstly, it can facilitate entry into new market segments by commercializing a product superior in performance and environmental sustainability. This could diversify revenue streams and potentially increase market share globally. Additionally, it promotes innovation alignment with environmental and sustainability trends, enhancing brand value. The component's biodegradable nature meets increasing regulatory and consumer demands for green products, positioning Brilliant Bhd. favorably against competitors. Lastly, leveraging this technology could strengthen existing customer relationships by offering advanced products, thus driving long-term growth beyond its stagnant recent years .
Changes in expected selling price inflation and operating cost inflation can significantly impact the investment decision for CG Pharmaceutical Bhd.'s drug Z10. If selling price inflation (2% per year) exceeds operating cost inflation (5% per year), the real profitability may decline due to increasing operational costs exceeding revenue gains, thereby reducing the net present value (NPV) and internal rate of return (IRR) of the investment. This imbalance could affect the attractiveness of the project given the company's required return on capital employed of 28% per year. Analyzing these figures is crucial in making an informed decision on whether the projected returns justify the risks and costs associated with this investment .
Brilliant Bhd.'s potential investment in new technology carries financial risks related to its current capital structure, with a gearing ratio of 20%. The investment requires substantial upfront costs (RM21 million in assessment and feasibility fees) before any revenue is realized, increasing financial exposure. The addition of RM20 million for licensing further increases leverage if financed through debt, impacting debt covenants and financial stability. Operational risk includes achieving projected cash flows amidst market competition and environmental legislation changes. Additionally, the assumption of unchanged risk profile post-investment might underestimate the potential volatility in required returns due to strategic shifts in product offerings .
Capital allowance impacts the net present value (NPV) calculation for Brilliant Bhd.'s proposed investment by reducing taxable income through depreciation deductions, which consequently lowers tax liabilities. The capital allowance is claimable on a 10% straight-line basis starting from the end of year 2. The resultant tax savings from these allowances enhance cash flows, improving the NPV. Since these savings begin in year 2 and occur in real terms, they are timed with the project life, directly influencing the financial feasibility of the investment by boosting value returned relative to the invested capital .
When evaluating the internal rate of return (IRR) for Duo Co's new machine investment, key factors to consider include the initial cash outflow, forecasted incremental cash inflows from increased production capacity, and salvage value of the machine. It's crucial to assess whether the IRR meets or exceeds the company's cost of capital to ensure it adds value. Furthermore, consider any risks related to demand forecasts, as underperformance could lead to cash flow shortfalls. Also, tax implications from capital allowances affecting net cash returns are important as they enhance post-tax income, contributing to an IRR comparison against the weighted average cost of capital .
Duo Co's tax position critically affects the net present value (NPV) by influencing cash flows through tax payments deferred by one year, at a rate of 30%. Capital allowances on a 25% reducing balance basis decrease taxable income, generating tax shields which enhance cash flow post-tax. Over four years, these allowances reduce the net present cost by increasing after-tax cash inflows. Accurately incorporating these elements in the NPV calculation reinforces the investment's feasibility by showing whether it generates value over its cost, with tax savings significantly impacting the financial returns .
The financial implication of investing in the new machine involves comparing the net present value (NPV) to the after-tax weighted average cost of capital (WACC). Duo Co's WACC is determined by its capital structure consisting of 80% equity and 20% debt, with the cost of equity at 11% and the before-tax cost of debt at 8.6%. The NPV will consider additional production capacity of 600,000 kg/year and capital investment of $800,000, against future demands which exceed current capacity. High demand forecasts (1.4 to 1.7 million kg/year over four years) compared to current capacity necessitate this investment, which must yield an NPV that exceeds the after-tax WACC to be considered financially viable .
Brilliant Bhd.'s beta of 1.1 indicates a sensitivity to market variations slightly above the overall market, affecting the equity cost component in WACC calculation. The market risk premium of 7% is multiplied by the beta to determine the equity risk premium, added to the risk-free rate (3.55%), thus setting a higher equity cost, reflecting the risk profile. This, in combination with a 20% debt gearing, influences the WACC used in appraising whether the expected return on an investment surpasses the cost of capital. A higher WACC demands a higher project return to be viable, thus playing a crucial role in the investment appraisal .